Literature DB >> 7353268

Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine.

P Fossati, L Prencipe, G Berti.   

Abstract

A new direct colorimetric procedure for uric acid assay in serum or urine is described, utilizing a 3,5-dichloro-2-hydroxybenzene sulfonic acid/4-aminophenazone chromogenic system in the presence of horseradish peroxidase and uricase from Aspergillus flavus. This chromogen system has a high absorptivity, affording useful results with sample/reagent volume ratios as low as 0.025. The procedure is applicable to serum, plasma, or diluted urine. A single working reagent is used; the reaction is complete in less than 15 min at room temperature. The red dye formed is measured at 520 nm; a blank sample measurement is not needed. The standard curve for the method is linear for uric acid concentrations up to 1500 mumol/L. Average analytical recovery of uric acid in human sera and urine exceeded 99%; within-run and between-run precision studies showed CV's of less than or equal to 1.2 and less than or equal to 2.2%, respectively. The new procedure correlated well with the uricase/catalase and uricase/ultraviolet methods. The method is suitable for automation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7353268

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  158 in total

1.  Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity.

Authors:  Lila K Habib; Michelle T C Lee; Jerry Yang
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  Protection against hydrogen peroxide cytotoxicity in rat-1 fibroblasts provided by the oncoprotein Bcl-2: maintenance of calcium homoeostasis is secondary to the effect of Bcl-2 on cellular glutathione.

Authors:  M M Rimpler; U Rauen; T Schmidt; T Möröy; H de Groot
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  Oxidative damage is present in plasma and circulating neutrophils 4 weeks after a high mountain expedition.

Authors:  Lucrecia Carrera-Quintanar; Miguel Lopez-Fuertes; Vicente Climent; Maria Herranz-Lopez; Vicente Micol; Antoni Pons; Francisco Sogorb; Enrique Roche
Journal:  Eur J Appl Physiol       Date:  2011-12-06       Impact factor: 3.078

4.  Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.

Authors:  Shameez Allie-Hamdulay; Allen L Rodgers
Journal:  Urol Res       Date:  2005-05-04

5.  Anti-Eimeria activity of berberine and identification of associated gene expression changes in the mouse jejunum infected with Eimeria papillata.

Authors:  Mohamed A Dkhil; Mahmoud S Metwaly; Saleh Al-Quraishy; Nour E Sherif; Denis Delic; Suliman Y Al Omar; Frank Wunderlich
Journal:  Parasitol Res       Date:  2015-02-10       Impact factor: 2.289

6.  Metabolic parameters after changing from hydrochlorothiazide to verapamil treatment in hypertension.

Authors:  A Lehtonen; A Gordin
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease.

Authors:  Renato Ribeiro Nogueira Ferraz; Jonathan Mackowiak Fonseca; Gregory George Germino; Luiz Fernando Onuchic; Ita Pfeferman Heilberg
Journal:  Urolithiasis       Date:  2014-05-10       Impact factor: 3.436

8.  Toxicological Responses of Chlorella vulgaris to Dichloromethane and Dichloroethane.

Authors:  Shijin Wu; Huaxing Zhang; Xiang Yu; Lequan Qiu
Journal:  Environ Eng Sci       Date:  2014-01-01       Impact factor: 1.907

9.  Nephroprotective Effect of Pleurotus ostreatus and Agaricus bisporus Extracts and Carvedilol on Ethylene Glycol-Induced Urolithiasis: Roles of NF-κB, p53, Bcl-2, Bax and Bak.

Authors:  Osama M Ahmed; Hossam Ebaid; El-Shaymaa El-Nahass; Mahmoud Ragab; Ibrahim M Alhazza
Journal:  Biomolecules       Date:  2020-09-14

10.  Mandibular advancement device and CPAP upon cardiovascular parameters in OSA.

Authors:  Cibele Dal-Fabbro; Silvério Garbuio; Vânia D'Almeida; Fátima D Cintra; Sergio Tufik; Lia Bittencourt
Journal:  Sleep Breath       Date:  2014-01-26       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.